BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/29/2018 12:59:07 AM | Browse: 102 | Download: 23
Publication Name World Journal of Pharmacology
Manuscript ID 41201
Country of Manuscript Source United Kingdom
Received
2018-07-27 12:51
Peer-Review Started
2018-07-29 10:52
To Make the First Decision
2018-08-31 00:30
Return for Revision
2018-09-03 02:22
Revised
2018-09-05 21:14
Second Decision
2018-09-29 08:40
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-10-13 02:02
Articles in Press
2018-10-13 02:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-10-20 09:00
Publish the Manuscript Online
2018-10-22 09:50
ISSN 2220-3192 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Pharmacology and Pharmacy
Manuscript Type Editorial
Article Title Kv7 channels a potential therapeutic target in fibromyalgia: A hypothesis
Manuscript Source Invited Manuscript
All Author List Kim Lawson
Funding Agency and Grant Number
Correspondence To Kim Lawson, PhD, Senior Lecturer, Department of Biosciences and Chemistry, Biomolecular Sciences Research Centre, Sheffield Hallam University, City Campus, Howard Street, Sheffield S1 1WB, United Kingdom. k.lawson@shu.ac.uk
Keywords Fibromyalgia; Persistent pain; Potassium channels; Kv7 channels; Flupirtine; Retigabine
Core Tip Fibromyalgia a multifaceted disorder remains a major unmet condition with current therapies providing limited control. An involvement of potassium channels in the pathophysiology of fibromyalgia and the related symptoms is emerging, and Kv7 channel activators, such as flupirtine and retigabine, exhibit pharmacological profiles compatible with the requirements of therapeutic approaches to fibromyalgia. Focused clinical trials with flupirtine and retigabine will provide important insight to the role of potassium channels and the utility of Kv7 channel activators in fibromyalgia.
Publish Date 2018-10-22 09:50
Citation Lawson K. Kv7 channels a potential therapeutic target in fibromyalgia: A hypothesis. World J Pharmacol 2018; 7(1): 1-9
Url http://www.wjgnet.com/2220-3192/full/v7/i1/1.htm
DOI http://dx.doi.org/10.5497/wjp.v7.i1.1
Full Article (PDF) WJP-7-1.pdf
Full Article (Word) WJP-7-1.doc
Revised Manuscript 41201-Review.docx
Peer-review Report 41201-Peer-review(s).pdf
Answering Reviewers 41201-Answering reviewers.pdf
Scientific Misconduct Check 41201-Scientific misconduct check.pdf
Scientific Editor Work List 41201-Scientific editor work list.pdf
Audio Core Tip 41201-Audio core tip.wav
Conflict-of-Interest Disclosure Form 41201-Conflict-of-interest statement.pdf
Copyright License Agreement 41201-Copyright assignment.pdf